Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte BLOG

DDW Magazine Interviews Labcyte Customer Chris Voigt of MIT about Synthetic Biology
TUESDAY, AUGUST 09, 2016
linkedin twitter facebook |  40Shares

The summer issue of Drug Discovery World magazine contains a great interview about synthetic biology with our customer Chris Voigt, a professor of biological engineering at MIT.


Various market research studies have pegged the value of the global synthetic biology market at about $5 billion, with compound annual growth expected to be as much as 35 percent for the next several years. Interest from pharmaceutical and biotech companies is one of the main drivers for the increased demand. DDW chatted with Voigt to learn more about the impact this field will have on pharmaceutical workflows and drug pipelines.


Synthetic biology is an important emerging application for our Echo Liquid Handlers. Powered by acoustic droplet ejection technology, Echo Liquid Handlers can be used to transfer nanoliter-sized droplets quickly and precisely, allowing reactions volumes to be reduced by up to 100-fold and drastically reducing experimental costs. In addition, transfer volumes as low as 2.5 nanoliters can extend the useful life of primer libraries and eliminate the need to dilute high concentration primers, saving on storage and primer costs, and preventing dilution errors. In addition to miniaturization, the Echo system can rapidly pool oligos or DNA fragments from library plates. Echo liquid handlers can transfer each oligo or fragment from any well of a microplate in less than a second, and contact-free transfers mean there’s no time wasted changing or washing tips. In a high-throughput setting, customers can save 10-15 hours of time per day. You can read more about our solutions for synthetic biology here.



READ the FULL INTERVIEW